Vaxart, Inc. (VXRT)
0.5016
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Vaxart Shareholders Equity (Quarterly) : 82.37M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 82.37M |
| March 31, 2026 | 94.12M |
| December 31, 2025 | 87.80M |
| September 30, 2025 | 26.76M |
| June 30, 2025 | 32.88M |
| March 31, 2025 | 45.62M |
| December 31, 2024 | 58.92M |
| September 30, 2024 | 68.44M |
| June 30, 2024 | 80.01M |
| March 31, 2024 | 55.69M |
| December 31, 2023 | 57.80M |
| September 30, 2023 | 71.52M |
| June 30, 2023 | 85.07M |
| March 31, 2023 | 89.75M |
| December 31, 2022 | 110.60M |
| September 30, 2022 | 122.31M |
| June 30, 2022 | 143.09M |
| March 31, 2022 | 166.36M |
| December 31, 2021 | 187.53M |
| September 30, 2021 | 204.95M |
| June 30, 2021 | 199.78M |
| March 31, 2021 | 176.24M |
| December 31, 2020 | 123.40M |
| September 30, 2020 | 131.68M |
| June 30, 2020 | 40.24M |
| Date | Value |
|---|---|
| March 31, 2020 | 31.29M |
| December 31, 2019 | 12.95M |
| September 30, 2019 | 18.90M |
| June 30, 2019 | 15.84M |
| March 31, 2019 | 12.58M |
| December 31, 2018 | 11.24M |
| September 30, 2018 | 15.99M |
| June 30, 2018 | 22.35M |
| March 31, 2018 | 31.11M |
| June 30, 2017 | 18.70M |
| March 31, 2017 | 24.20M |
| December 31, 2016 | 28.00M |
| September 30, 2016 | 36.60M |
| June 30, 2016 | 46.20M |
| March 31, 2016 | 52.70M |
| December 31, 2015 | 57.50M |
| September 30, 2015 | 63.50M |
| June 30, 2015 | 69.50M |
| March 31, 2015 | 81.50M |
| December 31, 2014 | 82.40M |
| September 30, 2014 | 77.90M |
| June 30, 2014 | 86.90M |
| March 31, 2014 | 96.00M |
| December 31, 2013 | 64.20M |
| September 30, 2013 | 64.90M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 165.18M |
| Total Liabilities (Quarterly) | 82.81M |
| Debt to Equity Ratio | 0.1522 |
| Current Ratio | 1.596 |
| Net Debt Paydown Yield | 1.09% |